• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水分产生共晶体的机制。

Mechanisms by which moisture generates cocrystals.

作者信息

Jayasankar Adivaraha, Good David J, Rodríguez-Hornedo Naír

机构信息

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109-1065, USA.

出版信息

Mol Pharm. 2007 May-Jun;4(3):360-72. doi: 10.1021/mp0700099. Epub 2007 May 8.

DOI:10.1021/mp0700099
PMID:17488034
Abstract

The purpose of this study is to determine the mechanisms by which moisture can generate cocrystals when solid particles of cocrystal reactants are exposed to deliquescent conditions (when moisture sorption forms an aqueous solution). It is based on the hypothesis that cocrystallization behavior during water uptake can be derived from solution chemistry using models that describe cocrystal solubility and reaction crystallization of molecular complexes. Cocrystal systems were selected with active pharmaceutical ingredients (APIs) that form hydrates and include carbamazepine, caffeine, and theophylline. Moisture uptake and crystallization behavior were studied by gravimetric vapor sorption, X-ray powder diffraction, and on-line Raman spectroscopy. Results indicate that moisture uptake generates cocrystals of carbamazepine-nicotinamide, carbamazepine-saccharin, and caffeine or theophylline with dicarboxylic acid ligands (oxalic acid, maleic acid, glutaric acid, and malonic acid) when solid mixtures with cocrystal reactants deliquesce. Microscopy studies revealed that the transformation mechanism to cocrystal involves (1) moisture uptake, (2) dissolution of reactants, and (3) cocrystal nucleation and growth. Studies of solid blends of reactants in a macro scale show that the rate and extent of cocrystal formation are a function of relative humidity, moisture uptake, deliquescent material, and dissolution rates of reactants. It is shown that the interplay between moisture uptake and dissolution determines the liquid phase composition, supersaturation, and cocrystal formation rates. Differences in the behavior of deliquescent additives (sucrose and fructose) are associated with moisture uptake and composition of the deliquesced solution. Our results show that deliquescence can transform API to cocrystal or reverse the reaction given the right conditions. Key indicators of cocrystal formation and stability are (1) moisture uptake, (2) cocrystal aqueous solubility, (3) solubility and dissolution of cocrystal reactants, and (4) transition concentration.

摘要

本研究的目的是确定当共晶反应物的固体颗粒暴露于潮解条件下(即吸湿形成水溶液时)水分能够生成共晶的机制。其基于这样一个假设,即吸水过程中的共结晶行为可以通过使用描述共晶溶解度和分子络合物反应结晶的模型从溶液化学推导得出。选择了含有形成水合物的活性药物成分(API)的共晶体系,包括卡马西平、咖啡因和茶碱。通过重量法蒸汽吸附、X射线粉末衍射和在线拉曼光谱研究了吸湿和结晶行为。结果表明,当与共晶反应物的固体混合物潮解时,吸湿会生成卡马西平 - 烟酰胺、卡马西平 - 糖精以及咖啡因或茶碱与二羧酸配体(草酸、马来酸、戊二酸和丙二酸)的共晶。显微镜研究表明,向共晶的转变机制涉及(1)吸湿,(2)反应物溶解,以及(3)共晶成核和生长。对宏观尺度下反应物固体混合物的研究表明,共晶形成的速率和程度是相对湿度、吸湿量、潮解物质以及反应物溶解速率的函数。结果表明,吸湿与溶解之间的相互作用决定了液相组成、过饱和度和共晶形成速率。潮解添加剂(蔗糖和果糖)行为的差异与吸湿量和潮解溶液的组成有关。我们的结果表明,在合适的条件下,潮解可以将API转化为共晶或使反应逆转。共晶形成和稳定性的关键指标是(1)吸湿量,(2)共晶在水中的溶解度,(3)共晶反应物的溶解度和溶解情况,以及(4)转变浓度。

相似文献

1
Mechanisms by which moisture generates cocrystals.水分产生共晶体的机制。
Mol Pharm. 2007 May-Jun;4(3):360-72. doi: 10.1021/mp0700099. Epub 2007 May 8.
2
Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.通过纯研磨和液辅助研磨筛选药物共晶水合物
Mol Pharm. 2007 May-Jun;4(3):347-54. doi: 10.1021/mp0700054. Epub 2007 May 12.
3
Physical stability enhancement of theophylline via cocrystallization.通过共结晶提高茶碱的物理稳定性
Int J Pharm. 2006 Aug 31;320(1-2):114-23. doi: 10.1016/j.ijpharm.2006.04.018.
4
Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.水存在下的共晶体解离:一种鉴定稳定共晶体形式的通用方法。
J Pharm Sci. 2014 Sep;103(9):2865-2870. doi: 10.1002/jps.24003. Epub 2014 May 13.
5
An investigation of the causes of cocrystal dissociation at high humidity.高湿度下共晶体解离原因的研究。
J Pharm Sci. 2014 Sep;103(9):2859-2864. doi: 10.1002/jps.23865. Epub 2014 Jan 30.
6
Reaction crystallization of pharmaceutical molecular complexes.药物分子复合物的反应结晶
Mol Pharm. 2006 May-Jun;3(3):362-7. doi: 10.1021/mp050099m.
7
Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy.通过原子力显微镜观察咖啡因共晶体在可控湿度储存条件下的表面响应。
Int J Pharm. 2009 Sep 8;379(1):59-66. doi: 10.1016/j.ijpharm.2009.06.009. Epub 2009 Jun 17.
8
In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.原位监测卡马西平-烟酰胺共晶的内在溶解行为。
Eur J Pharm Biopharm. 2013 Apr;83(3):415-26. doi: 10.1016/j.ejpb.2012.10.005. Epub 2012 Nov 16.
9
Theophylline-nicotinamide cocrystal formation in physical mixture during storage.茶碱-烟酰胺共晶在储存过程中物理混合物的形成。
Int J Pharm. 2015;486(1-2):121-30. doi: 10.1016/j.ijpharm.2015.03.012. Epub 2015 Mar 20.
10
Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid.超声辅助溶液共结晶法(USSC)中包含非一致可溶共晶组分对:咖啡因/马来酸。
Eur J Pharm Sci. 2010 Dec 23;41(5):597-602. doi: 10.1016/j.ejps.2010.08.012. Epub 2010 Aug 27.

引用本文的文献

1
Current Perspectives on Development and Applications of Cocrystals in the Pharmaceutical and Medical Domain.共晶在制药和医学领域的发展与应用现状
Cureus. 2024 Sep 27;16(9):e70328. doi: 10.7759/cureus.70328. eCollection 2024 Sep.
2
Spontaneous Synthesis of [Fe (Atrz) ]SO and its Analogues Through Accelerated Ageing: New Insights from Small-Scale Reactions.通过加速老化自发合成[Fe(Atrz)]SO及其类似物:小规模反应的新见解
Chemistry. 2022 Nov 16;28(64):e202201823. doi: 10.1002/chem.202201823. Epub 2022 Sep 19.
3
A co-crystal berberine-ibuprofen improves obesity by inhibiting the protein kinases TBK1 and IKKɛ.
盐酸小檗碱-布洛芬共晶通过抑制蛋白激酶 TBK1 和 IKKɛ 改善肥胖。
Commun Biol. 2022 Aug 12;5(1):807. doi: 10.1038/s42003-022-03776-0.
4
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.药物共晶体:制备、物理化学性质及应用综述
Acta Pharm Sin B. 2021 Aug;11(8):2537-2564. doi: 10.1016/j.apsb.2021.03.030. Epub 2021 Mar 23.
5
Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.通过反应结晶法制备共晶体:药物应用
Pharmaceutics. 2021 Jun 17;13(6):898. doi: 10.3390/pharmaceutics13060898.
6
Predicting Deliquescence Relative Humidities of Crystals and Crystal Mixtures.预测晶体和晶体混合物的开始潮解相对湿度。
Molecules. 2021 May 26;26(11):3176. doi: 10.3390/molecules26113176.
7
Stability of Pharmaceutical Co-Crystals at Humid Conditions Can Be Predicted.药物共晶体在潮湿条件下的稳定性可以被预测。
Pharmaceutics. 2021 Mar 23;13(3):433. doi: 10.3390/pharmaceutics13030433.
8
Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.制备难溶性药物的共晶体以提高其在水性介质中的溶出度
Pharmaceutics. 2018 Jul 31;10(3):108. doi: 10.3390/pharmaceutics10030108.
9
Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.用于改善药物溶解度和吸收的共无定形固体分散体:组成、制备、表征及口服给药制剂
Pharmaceutics. 2018 Jul 19;10(3):98. doi: 10.3390/pharmaceutics10030098.
10
Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.药用共晶体:监管与战略层面、设计与开发
Adv Pharm Bull. 2016 Dec;6(4):479-494. doi: 10.15171/apb.2016.062. Epub 2016 Dec 22.